Sanofi (SNY) Finished Goods (2015 - 2018)
Sanofi (SNY) posted Finished Goods of $2.7 billion for Q4 2018, up 6.3% sequentially from $2.5 billion in Q4 2017, and up 6.3% YoY from $2.5 billion in Q4 2017.
Sanofi (SNY) Finished Goods (2015 - 2018) Analysis & Trends
Sanofi has reported Finished Goods for 4 years, with the latest figure at $2.7 billion in Q4 2018.
- Quarterly Finished Goods rose 6.3% year-over-year to $2.7 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $2.7 billion (up 6.3% YoY) and the FY2018 annual result came in at $2.8 billion, up 14.71% from the prior year.
- Finished Goods grew to $2.7 billion in Q4 2018 per SNY's latest filing, from $2.5 billion in the prior quarter.
- Over five years, Finished Goods peaked at $2.7 billion in Q4 2018 and troughed at $2.3 billion in Q4 2015.
- A 4-year average of $2.5 billion and a median of $2.4 billion in 2017 frame the typical range for Finished Goods.
- The sharpest annual moves came in 2016 and 2017: Finished Goods advanced 1.88% in 2016, then grew 10.02% in 2017.
- Over 4 years, Finished Goods stood at $2.3 billion in 2015, then climbed by 1.88% to $2.3 billion in 2016, then grew by 10.02% to $2.5 billion in 2017, then increased by 6.3% to $2.7 billion in 2018.
- According to Business Quant data, Finished Goods over the past three periods registered $2.7 billion, $2.5 billion, and $2.3 billion for Q4 2018, Q4 2017, and Q4 2016 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.18 Bn | 632.42 Bn | 17.26 Bn |
| 2 | AbbVie | 470.13 Bn | 463.56 Bn | 12.70 Bn |
| 3 | Merck | 376.16 Bn | 369.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.69 Bn | 295.00 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.73 Bn | 252.83 Bn | 12.86 Bn |
| 6 | Amgen | 236.53 Bn | 222.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.21 Bn | 180.03 Bn | 6.22 Bn |
| 8 | Pfizer | 160.17 Bn | 148.47 Bn | 10.94 Bn |
| 9 | Gsk | 105.91 Bn | 101.75 Bn | 8.24 Bn |
| 10 | Sanofi | 55.25 Bn | 47.87 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 2.71 Bn |
| Dec 31, 2017 | 2.55 Bn |
| Dec 31, 2016 | 2.32 Bn |
| Dec 31, 2015 | 2.27 Bn |